摘要目的 分析麻芩消咳颗粒治疗急性咳嗽的临床效果。方法 选取2020年3月至2021年3月东莞东华医院收治的80 例急性咳嗽患者作为研究对象进行回顾性分析,按照治疗方法的不同将患者分为常规组(n=40)及治疗组(n=40)。 常规组患者采用美敏伪麻溶液治疗,治疗组患者采用麻芩消咳颗粒治疗。 比较两组患者的治疗效果、中医证候评分、肺功能、2 min 内咳嗽次数及不良反应发生情况。 结果 治疗组患者的治疗总有效率(85.00%)高于常规组(60.00%),差异有统计学意义(P<0.05)。两组患者治疗前的咳嗽、咳痰、发热、气喘、日间咳嗽及夜间咳嗽等中医证候评分比较,差异无统计学意义(P>0.05);治疗组患者治疗后的咳嗽、咳痰、发热、气喘、日间咳嗽及夜间咳嗽等中医证候评分低于常规组,且两组患者治疗后的咳嗽、咳痰、发热、气喘、日间咳嗽及夜间咳嗽等中医证候评分均低于本组治疗前,差异有统计学意义(P<0.05)。两组患者治疗前的肺活量(FVC)、第一秒用力呼气容积(FEV1)及呼气流量峰值(PEF)水平比较,差异无统计学意义(P>0.05);治疗组患者治疗后的FVC、FEV1、PEF 水平高于常规组,且两组患者治疗后的FVC、FEV1、PEF 水平均高于本组治疗前,差异有统计学意义(P<0.05)。 两组患者治疗前的2 min 内咳嗽次数比较,差异无统计学意义(P>0.05);治疗组患者治疗后的2 min 内咳嗽次数少于常规组,且两组患者治疗后的2 min 内咳嗽次数均少于本组治疗前,差异有统计学意义(P<0.05)。治疗组患者的不良反应总发生率(7.50%)与常规组(12.50%)比较,差异无统计学意义(P>0.05)。结论 应用麻芩消咳颗粒治疗急性咳嗽的效果显著,可有效促进患者的相关症状消失,降低中医证候评分,并起到良好的肺功能保护作用,改善肺功能水平,减少患者咳嗽次数,且安全性较高,用药后不良反应较少,在急性咳嗽临床治疗中具有重要意义,临床治疗价值较高,建议采纳并推广。
Objective To analyze the clinical effect of Maqin Xiaoke Granules on acute cough. Methods A total of 80 patients with acute cough admitted in the Donghua Donghua Hospital from March 2020 to March 2021 were selected as the research subjects for a retrospective analysis. According to different therapeutic methods, they were divided into a conventional group (n=40) and a treatment group (n=40). The patients in the conventional group were treated with Compound Pseudoephedrine Hydrochloride Solution, and the patients in the treatment group were treated with Maqin Xiaoke Granules. The treatment effect, traditional Chinese medicine syndrome score, pulmonary function, number of coughs within 2 min and the occurrence of adverse reactions were compared between the two groups. Results The total effectiveness rate of treatment in the treatment group was 85.00%, higher than that in the conventional group accounting for 60.00%, and the difference was statistically significant (P<0.05). There were no significant differences in traditional Chinese medicine syndrome scores of cough, expectoration, fever, asthma, daytime cough and night cough before treatment between the two groups (P>0.05). After treatment, the traditional Chinese medicine syndrome scores of cough, expectoration, fever, asthma, daytime cough and night cough in the treatment group after treatment were lower than those in the conventional group, and the traditional Chinese medicine syndrome scores of cough, expectoration,fever, asthma, daytime cough and night cough in the two groups after treatment were lower than those in the same group before treatment, and the differences were statistically significant (P<0.05). There were no significant differences in the levels of forced vital capacity (FVC), forced expiratory volume in one second (FEV1) or peak expiratory flow (PEF) between the two groups before treatment (P>0.05). The levels of FVC, FEV1, and PEF after treatment in the treatment group were higher than those in the conventional group, and the levels of FVC, FEV1, and PEF in the two groups after treatment were higher than those before treatment, and the differences were statistically significant (P<0.05). The number of coughs within 2 min in the two groups before treatment did not show statistical significance (P>0.05). After treatment, the number of coughs within 2 min in the treatment group was less than that in the conventional group, and the number of coughs in the two groups within 2 min after treatment was less than that before treatment in the same group,and the differences were statistically significant (P<0.05). The total incidence of adverse reactions in the treatment group was 7.50%, which was not significantly different from that in the conventional group, 12.50% (P>0.05). Conclusion The application of Maqin Xiaoke Granules has a remarkable therapeutic effect. It can effectively promote the disappearance of related symptoms, reduce the traditional Chinese medicine syndrome score, and play a good role in protecting and improving lung function, and reducing the number of coughs in high safety. There are few adverse reactions after medication, which is of great significance in the clinical treatment of acute cough, and has high clinical therapeutic value. It is recommended to be adopted and promoted.